OTK18 expression in brain mononuclear phagocytes parallels the severity of HIV-1 encephalitis

Journal of Neuroimmunology

Volumn 150, Issue 1-2, 2004, Pages 186-198

  Carlson, Kimberly A ^a,d   Limoges, Jenae ^a   Pohlman, Garrett D ^a   Poluektova, Larisa Y ^a   Langford, Dianne ^b   Masliah, Eliezer ^b   Ikezu, Tsuneya ^a   Gendelman, Howard E ^a,c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NEBRASKA MEDICAL CENTER   (United States)

^d UNIVERSITY OF NEBRASKA AT KEARNEY   (United States)

Author keywords

Disease markers; HIV 1 encephalitis; Macrophages; Microglia; Transcriptional factor

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR OTK18; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; BRAIN; CONTROLLED STUDY; CYTOMEGALOVIRUS; DIFFERENTIAL DISPLAY; DISEASE COURSE; DISEASE SEVERITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MONONUCLEAR PHAGOCYTE; MULTIPLE SCLEROSIS; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE LEVEL; VIRUS ENCEPHALITIS;

AIDS DEMENTIA COMPLEX; BRAIN; CELLS, CULTURED; DISEASE PROGRESSION; DNA-BINDING PROTEINS; ENCEPHALITIS, VIRAL; GENE EXPRESSION REGULATION; HIV-1; HUMANS; MACROPHAGES; ORGAN SPECIFICITY; SEVERITY OF ILLNESS INDEX; TRANSCRIPTION FACTORS; VIRUS REPLICATION;

EID: 1842687445     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2004.01.021     Document Type: Article

References (59)

1. Abel K., Alegria-Hartman M.J., Rothaeusler K., Marthas M., Miller C.J. The relationship between simian immunodeficiency virus RNA levels and the mRNA levels of alpha/beta interferons (IFN-alpha/beta) and IFN-alpha/beta-inducible Mx in lymphoid tissues of rhesus macaques during acute and chronic infection. J. Virol. 76:2002;8433-8445.
2. Achim C.L., Wang R., Miners D.K., Wiley C.A. Brain viral burden in HIV infection. J. Neuropathol. Exp. Neurol. 53:1994;284-294.
3. Adamson D.C., Wildemann B., Sasaki M., Glass J.D., McArthur J.C., Christov V.I., Dawson T.M., Dawson V.L. Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science. 274:1996;1917-1921.
4. Akridge R.E., Oyafuso L.K., Reed S.G. IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. J. Immunol. 153:1994;5782-5789.
5. Anderson E., Zink W., Xiong H., Gendelman H.E. HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes. J. Acquir. Immune Defic. Syndr. 31(Suppl. 2):2002;S43-S54.
6. Bellefroid E.J., Poncelet D.A., Lecocq P.J., Revelant O., Martial J.A. The evolutionarily conserved kruppel-associated box domain defines a subfamily of eukaryotic multifingered proteins. Proc. Natl. Acad. Sci. U. S. A. 88:1991;3608-3612.
7. Breen E.C., Rezai A.R., Nakajima K., Beall G.N., Mitsuyasu R.T., Hirano T., Kishimoto T., Martinez-Maza O. Infection with HIV is associated with elevated IL-6 levels and production. J. Immunol. 144:1990;480-484.
8. Budka H. Multinucleated giant cells in brain: a hallmark of the acquired immune deficiency syndrome (AIDS). Acta Neuropathol. (Berl.). 69:1986;253-258.
9. Carlson K., Leisman G., Limoges J., Pohlman G., Horiba M., Buescher J., Gendelman H., Ikezu T. Molecular characterization of a putative anti-retroviral transcriptional factor, OTK18. J. Immunol. 172:2004;381-391.
10. Cherner M., Masliah E., Ellis R.J., Marcotte T.D., Moore D.J., Grant I., Heaton R.K. Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis. Neurology. 59:2002;1563-1567.
11. Dickson D.W., Mattiace L.A., Kure K., Hutchins K., Lyman W.D., Brosnan C.F. Microglia in human disease, with an emphasis on acquired immune deficiency syndrome. Lab. Invest. 64:1991;135-156.
12. Diesing T.S., Swindells S., Gelbard H., Gendelman H.E. HIV-1-associated dementia: a basic science and clinical perspective. AIDS Read. 12:2002;358-368.
13. Dore G.J., Cooper D.A., Barrett C., Goh L.E., Thakrar B., Atkins M. Dual efficacy of lamivudine treatment in human immunodeficiency virus/hepatitis B virus-coinfected persons in a randomized, controlled study (CAESAR). The CAESAR coordinating committee. J. Infect. Dis. 180:1999;607-613.
14. Emilie D., Peuchmaur M., Maillot M.C., Crevon M.C., Brousse N., Delfraissy J.F., Dormont J., Galanaud P. Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes. J. Clin. Invest. 86:1990;148-159.
15. Fauci A.S. Host factors and the pathogenesis of HIV-induced disease. Nature. 384:1996;529-534.
16. Francis M.L., Meltzer M.S., Gendelman H.E. Interferons in the persistence, pathogenesis, and treatment of HIV infection. AIDS Res. Hum. Retrovir. 8:1992;199-207.
17. Garba M.L., Pilcher C.D., Bingham A.L., Eron J., Frelinger J.A. HIV antigens can induce TGF-beta(1)-producing immunoregulatory CD8+T cells. J. Immunol. 168:2002;2247-2254.
18. Gelbard H.A., Dzenko K.A., DiLoreto D., del Cerro C., del Cerro M., Epstein L.G. Neurotoxic effects of tumor necrosis factor alpha in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: implications for AIDS neuropathogenesis. Dev. Neurosci. 15:1993;417-422.
19. Gelbard H.A., Nottet H.S., Swindells S., Jett M., Dzenko K.A., Genis P., White R., Wang L., Choi Y.B., Zhang D.et al. Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J. Virol. 68:1994;4628-4635.
20. Gendelman H.E. The neuropathogenesis of HIV-1-dementia: a panel discussion. Gendelman H.E., Lipton S.A., Epstein L., Swindells S. The Neurology of AIDS. 1998;1-10 Chapman & Hall, New York, NY.
21. Gendelman H.E., Orenstein J.M., Martin M.A., Ferrua C., Mitra R., Phipps T., Wahl L.A., Lane H.C., Fauci A.S., Burke D.S.et al. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J. Exp. Med. 167:1988;1428-1441.
22. Gendelman H.E., Baca L.M., Turpin J., Kalter D.C., Hansen B., Orenstein J.M., Dieffenbach C.W., Friedman R.M., Meltzer M.S. Regulation of HIV replication in infected monocytes by IFN-alpha. Mechanisms for viral restriction. J. Immunol. 145:1990;2669-2676.
23. Gendelman H.E., Persidsky Y., Ghorpade A., Limoges J., Stins M., Fiala M., Morrisett R. The neuropathogenesis of the AIDS dementia complex. Aids. 11:1997;S35-S45.
24. Gendelman H.E., Zheng J., Coulter C.L., Ghorpade A., Che M., Thylin M., Rubocki R., Persidsky Y., Hahn F., Reinhard J. Jr., Swindells S.et al. Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia. J. Infect. Dis. 178:1998;1000-1007.
25. Genis P., Jett M., Bernton E.W., Boyle T., Gelbard H.A., Dzenko K., Keane R.W., Resnick L., Mizrachi Y., Volsky D.J.et al. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J. Exp. Med. 176:1992;1703-1718.
26. Glass J.D., Fedor H., Wesselingh S.L., McArthur J.C. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann. Neurol. 38:1995;755-762.
27. Griffin D.E., Wesselingh S.L., McArthur J.C. Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia. Ann. Neurol. 35:1994;592-597.
28. Heyes M.P., Brew B.J., Martin A., Price R.W., Salazar A.M., Sidtis J.J., Yergey J.A., Mouradian M.M., Sadler A.E., Keilp J.et al. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann. Neurol. 29:1991;202-209.
29. Hussain L.A., Lehner T. Comparative investigation of Langerhans' cells and potential receptors for HIV in oral, genitourinary and rectal epithelia. Immunology. 85:1995;475-484.
30. Janssen H., Staf H., Been M. [A psychiatric patient with a HIV infection, what is to be done?]. TvZ. 1991;9-13.
31. Jiang Z.G., Piggee C., Heyes M.P., Murphy C., Quearry B., Bauer M., Zheng J., Gendelman H.E., Markey S.P. Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages. J. Neuroimmunol. 117:2001;97-107.
32. Kerr S.J., Armati P.J., Guillemin G.J., Brew B.J. Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex. Aids. 12:1998;355-363.
33. Kieburtz K., Schiffer R.B. Neurologic manifestations of human immunodeficiency virus infections. Neurol. Clin. 7:1989;447-468.
34. Koenig S., Gendelman H.E., Orenstein J.M., Dal Canto M.C., Pezeshkpour G.H., Yungbluth M., Janotta F., Aksamit A., Martin M.A., Fauci A.S. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science. 233:1986;1089-1093.
35. Kure K., Lyman W.D., Weidenheim K.M., Dickson D.W. Cellular localization of an HIV-1 antigen in subacute AIDS encephalitis using an improved double-labeling immunohistochemical method. Am. J. Pathol. 136:1990;1085-1092.
36. Lipton S.A. Human immunodeficiency virus-infected macrophages, gp120, and N-methyl-D-aspartate receptor-mediated neurotoxicity. Ann. Neurol. 33:1993;227-228.
37. Luo X., Carlson K.A., Wojna V., Mayo R., Biskup T.M., Stoner J., Anderson J., Gendelman H.E., Melendez L.M. Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment. Neurology. 60:2003;1931-1937.
38. Masliah E., Ge N., Achim C.L., Hansen L.A., Wiley C.A. Selective neuronal vulnerability in HIV encephalitis. J. Neuropathol. Exp. Neurol. 51:1992;585-593.
39. Molina J.M., Scadden D.T., Byrn R., Dinarello C.A., Groopman J.E. Production of tumor necrosis factor alpha and interleukin 1 beta by monocytic cells infected with human immunodeficiency virus. J. Clin. Invest. 84:1989;733-737.
40. Navia B.A., Price R.W. Clinical and biological features of the AIDS dementia complex. Swindells S. The Neurology of AIDS. 1998;229-240 Chapman & Hall, New York, NY.
41. Navia B.A., Jordan B.D., Price R.W. The AIDS dementia complex: I. Clinical features. Ann. Neurol. 19:1986;517-524.
42. Nottet H.S., Jett M., Flanagan C.R., Zhai Q.H., Persidsky Y., Rizzino A., Bernton E.W., Genis P., Baldwin T., Schwartz J.et al. A regulatory role for astrocytes in HIV-1 encephalitis. An overexpression of eicosanoids, platelet-activating factor, and tumor necrosis factor-alpha by activated HIV-1-infected monocytes is attenuated by primary human astrocytes. J. Immunol. 154:1995;3567-3581.
43. Persidsky Y., Ghorpade A., Rasmussen J., Limoges J., Liu X.J., Stins M., Fiala M., Way D., Kim K.S., Witte M.H., Weinand M., Carhart L., Gendelman H.E. Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis. Am. J. Pathol. 155:1999;1599-1611.
44. Poli G., Kinter A.L., Justement J.S., Bressler P., Kehrl J.H., Fauci A.S. Transforming growth factor beta suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage. J. Exp. Med. 173:1991;589-597.
45. Price R.W., Brew B. Management of the neurologic complications of HIV infection and AIDS. Infect. Dis. Clin. North Am. 2:1988;359-372.
46. Pulliam L., Gascon R., Stubblebine M., McGuire D., McGrath M.S. Unique monocyte subset in patients with AIDS dementia. Lancet. 349:1997;692-695.
47. Roux-Lombard P., Modoux C., Cruchaud A., Dayer J.M. Purified blood monocytes from HIV 1-infected patients produce high levels of TNF alpha and IL-1. Clin. Immunol. Immunopathol. 50:1989;374-384.
48. Saito H., Fujiwara T., Takahashi E.I., Shin S., Okui K., Nakamura Y. Isolation and mapping of a novel human gene encoding a protein containing zinc-finger structures. Genomics. 31:1996;376-379.
49. Sharer L.R., Cho E.S., Epstein L.G. Multinucleated giant cells and HTLV-III in AIDS encephalopathy. Hum. Pathol. 16:1985;760.
50. Swindells S., Baldwin T., Kelly C., Baca-Regen L., Loomis L., Post D., Brichacek B., Stevenson M., Dominguez E.A., Reddy R., Klein R., Liao M.J., Testa D., McDonald T., Bellanti J., Skurkovich S., Gendelman H.E. Regulation and characterization of the interferon-alpha present in patients with advanced human immunodeficiency virus type 1 disease. J. Interferon Cytokine Res. 16:1996;127-137.
51. Talley A.K., Dewhurst S., Perry S.W., Dollard S.C., Gummuluru S., Fine S.M., New D., Epstein L.G., Gendelman H.E., Gelbard H.A. Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA. Mol. Cell. Biol. 15:1995;2359-2366.
52. Tyor W.R., Glass J.D., Griffin J.W., Becker P.S., McArthur J.C., Bezman L., Griffin D.E. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann. Neurol. 31:1992;349-360.
53. Tyor W.R., Wesselingh S.L., Griffin J.W., McArthur J.C., Griffin D.E. Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 9:1995;379-388.
54. Uttamchandani R.B., Daikos G.L., Reyes R.R., Fischl M.A., Dickinson G.M., Yamaguchi E., Kramer M.R. Nocardiosis in 30 patients with advanced human immunodeficiency virus infection: clinical features and outcome. Clin. Infect. Dis. 18:1994;348-353.
55. von Sydow M., Sonnerborg A., Gaines H., Strannegard O. Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection. AIDS Res. Hum. Retrovir. 7:1991;375-380.
56. Weiss L., Haeffner-Cavaillon N., Laude M., Gilquin J., Kazatchkine M.D. HIV infection is associated with the spontaneous production of interleukin-1 (IL-1) in vivo and with an abnormal release of IL-1 alpha in vitro. Aids. 3:1989;695-699.
57. Wesselingh S.L., Power C., Glass J.D., Tyor W.R., McArthur J.C., Farber J.M., Griffin J.W., Griffin D.E. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann. Neurol. 33:1993;576-582.
58. Wiley C.A. Pathology of neurologic disease in AIDS. Psychiatr. Clin. North Am. 17:1994;1-15.
59. Zheng J., Gendelman H.E. The HIV-1 associated dementia complex: a metabolic encephalopathy fueled by viral replication in mononuclear phagocytes. Curr. Opin. Neurol. 10:1997;319-325.